Gufic Biosciences receives TGA Australia and ANVISA Brazil approval for Parecoxib 40mg injection
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
The brand has launched 6 new range of products to provide a complete pregnancy care solution
The products will be manufactured at the company's facility in Bengaluru
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
The company will develop and produce premixes for human nutrition applications
The state-of-the-art digital PETCT imaging system, highlights a significant advancement in the fight against cancer and detects other lesions offering patient centric services
These plant locations include Ramagundam, Talcher Kaniha, Korba, Vindhyachal, Dadri, Barh, Solapur, North Karanpura, and Mauda
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
Subscribe To Our Newsletter & Stay Updated